Follow Gartner to never miss an important update.
UBS set its price target for the research and advisory firm at $196. This is higher than the average analyst target of $169, which is right where the stock is trading today. While a price target is just one firm's estimate of what the stock is worth, it shows some confidence that the business can grow beyond its current valuation. Gartner remains a central player in how big companies decide to spend their technology budgets.
Source: UBS
BMO Capital maintained its Market Perform rating, which is a neutral stance that suggests the stock will likely perform in line with the broader market. The analyst lowered the price target from $214 to $206. Even with this slight reduction, the new target remains higher than the average analyst target of $169. This move suggests that while the firm still sees the business as stable, it is being more cautious about how much the stock can rise from here. For long-term owners, this doesn't change the core story of the company's role as a primary advisor for corporate technology spending, but it reflects a more conservative view on the stock's current price.
Source: BMO Capital
Truist Financial raised its price target for the stock from $170 to $205. This follows a strong quarterly report where the company earned more profit than analysts expected.
This target is now about 10 percent higher than the current stock price. It suggests the firm is becoming more confident that the company can keep growing its research business even as it spends more on its own operations.
Source: Truist Financial
The company announced a new conference in London for late September 2026. Analysts will work with corporate leaders on how to use AI and data to manage risk and audit tasks. Events like this are a key part of the business, as they help turn research into higher-priced consulting and ticket sales. While a single event is small, it shows the company is finding new ways to sell its expertise in high-demand areas like AI.
Source: Business Wire
The company reported adjusted earnings of $4.37 per share, which was well above the $3.76 analysts expected. Sales reached $1.68 billion, a small increase over last year when adjusted for currency swings.
Crucially, the total value of its research contracts grew to $5.3 billion. This is the most important number for the business because it shows that corporate tech leaders are still paying for its insights. The board also added 500 million dollars to its share repurchase plan, which is a way to return cash to shareholders by buying and retiring its own stock. Overall, the business remains a steady generator of cash, even if growth in new contracts is currently in the low single digits.
See the full quarter, and how our tracked metrics did
Source: 8-K filing
Management consistently sets a low bar and clears it, with eight straight quarters of earnings coming in well ahead of their own forecasts.
| Expectation | |
|---|---|
| EPS | $2.86 |
| Revenue | $1.49B |